http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007520522-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-401 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4738 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-401 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 |
| filingDate | 2005-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2007-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2007520522-A |
| titleOfInvention | Combination of (a) DNA topoisomerase inhibitor and (b) IAP inhibitor |
| abstract | The present invention relates to the treatment of proliferative diseases, particularly solid tumor diseases, comprising (a) a DNA topoisomerase inhibitor compound and (b) a compound that inhibits the caspase-9 inhibitory properties of apoptosis inhibitor protein (IAP) (IAP inhibitor). A pharmaceutical composition for such use; a pharmaceutical composition comprising such a combination; the use of such a combination for the manufacture of a medicament for the treatment of proliferative diseases; and thus as a combined preparation for simultaneous, separate or sequential use Commercial packages or products containing such combinations; and methods for treating warm-blooded animals, especially humans. |
| priorityDate | 2004-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 61.